SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001104659-18-062591
Filing Date
2018-10-17
Accepted
2018-10-17 20:43:39
Documents
4
Effectiveness Date
2018-10-17

Document Format Files

Seq Description Document Type Size
1 S-3MEF a18-36860_3s3mef.htm S-3MEF 86033
2 EX-5.1 a18-36860_3ex5d1.htm EX-5.1 14894
3 EX-23.1 a18-36860_3ex23d1.htm EX-23.1 2124
4 GRAPHIC g368603kii001.gif GRAPHIC 1275
  Complete submission text file 0001104659-18-062591.txt   105982
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-227880 | Film No.: 181127452
SIC: 2834 Pharmaceutical Preparations